Semaglutide — sold under brand names Ozempic and Wegovy — has changed the conversation around medical weight loss. In clinical trials, patients on a 2.4mg weekly dose lost an average of 15% of their body weight over 68 weeks when combined with lifestyle changes. That's a level of result previously only seen with bariatric surgery.
How GLP-1 medications actually work
GLP-1 (glucagon-like peptide-1) is a hormone your gut already produces after meals. It signals fullness to the brain, slows gastric emptying, and improves insulin sensitivity. Semaglutide is a long-acting version of that signal. Most patients describe the experience as "food noise turning off" — the constant background chatter about snacks and second helpings simply quiets down.
Who qualifies
- BMI ≥ 30, or BMI ≥ 27 with a weight-related condition (hypertension, type 2 diabetes, sleep apnea, high cholesterol)
- No personal or family history of medullary thyroid cancer or MEN2
- Not currently pregnant or planning pregnancy
- Willing to commit to weekly injections and monthly check-ins
What a guided program adds
GLP-1s work best inside a structured program, not on their own. ROX's weight-loss track pairs the medication with monthly provider check-ins, protein and hydration targets, dose adjustments based on tolerance, and screening for the side effects most commonly missed — gallbladder issues, dehydration, and muscle loss. We taper carefully and have a plan for what happens when you reach your goal, so the weight stays off.
If you've struggled with weight for years and the standard "eat less, move more" advice hasn't worked, it's worth a 30-minute consult to see whether this is a fit. Many patients describe it as the first treatment that actually addressed the biology behind their weight, not just the willpower.
Ready to talk to a provider?
Same-day virtual visits available across our service states.
Schedule a Visit
